TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 4

Investigational

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 17:36:05 GMT 2025` Edited by `admin` on `Tue Apr 01 17:36:05 GMT 2025`
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	115VXA358P
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 4

Common Name

English

ACT35 ANTIGEN

Preferred Name

English

TNFRSF4

Common Name

English

OX40

Common Name

English

CD134

Common Name

English

TAX TRANSCRIPTIONALLY-ACTIVATED GLYCOPROTEIN 1 RECEPTOR

Common Name

English

OX40L RECEPTOR

Common Name

English

Code System Code Type Description

FDA UNII

115VXA358P

Created by admin on Tue Apr 01 17:36:05 GMT 2025 , Edited by admin on Tue Apr 01 17:36:05 GMT 2025

PRIMARY

UNIPROT

P43489

Created by admin on Tue Apr 01 17:36:05 GMT 2025 , Edited by admin on Tue Apr 01 17:36:05 GMT 2025

PRIMARY

From	To
1_3	1_14
1_15	1_28
1_18	1_36
1_39	1_53
1_56	1_71
1_59	1_79
1_81	1_97
1_100	1_113
1_119	1_138

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_118
N	1_132

Related Record Type Details


					DT958C4NWR

CUDAROLIMAB

ACTIVATOR -> TARGET


					67GFR7JCMN

OXELUMAB

INHIBITOR -> TARGET


					C78148TF1D

VONLEROLIZUMAB

AGONIST -> TARGET

Amount:


					P9XVH8H2HF

BMS-986178

AGONIST -> TARGET


					C78148TF1D

VONLEROLIZUMAB

INHIBITOR -> TARGET


					PT47RQF9HF

Gimistotug

AGONIST -> TARGET

Interaction Type:

IN-VITRO

Amount:


					2Y83Y2ORD3

REVDOFILIMAB

AGONIST -> TARGET


					G770V925KP

Rocatinlimab

INHIBITOR -> TARGET

Amount:


					AKV2GM43DD

MEDI-6469

AGONIST -> TARGET

Amount:


					CT69TVL1KE

GSK-3174998

AGONIST -> TARGET


					0CRN540O4R

TELAZORLIMAB

INHIBITOR -> TARGET


					TA3CUZ8Y5M

Nuvustotug

AGONIST -> TARGET

Comments:

OX40, also known as cluster of differentiation (CD) 134 and tumor necrosis factor (TNF) receptor super family member 4 (TNFRSF4), is a receptor expressed primarily on activated CD4+ and CD8+ T cells. Receptor stimulation by the endogenous OX40 ligand (OX40L) or agonist OX40 antibodies can induce a co-stimulatory signal on T cell

Amount:


					4LU9B48U4D

TAVOLIMAB

AGONIST -> TARGET

Amount:


					CAN96F6UCF

FS-120

AGONIST -> TARGET

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL